MedTrace Logo

Clinical Investigation of Proclear® 1 Day and MyDay® Sphere Contact Lenses

NCT07104773 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2026-04-08

No results posted yet for this study

Summary

The aim of this study is to evaluate and compare the performance of two soft contact lenses.

Conditions

  • Ametropia
  • Myopia

Interventions

DEVICE

Control Lens (omafilcon A)

15 minutes of daily wear

DEVICE

Test Lens (stenfilcon A)

15 minutes of daily wear

Sponsors & Collaborators

  • Centre for Ocular Research & Education, Canada

    collaborator OTHER

  • CooperVision International Limited (CVIL)

    lead INDUSTRY

Principal Investigators

  • Jill Woods, MSc, MCOptom · Centre of Ocular Research and Education

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-24
Primary Completion
2025-08-21
Completion
2025-08-21
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07104773 on ClinicalTrials.gov